Management of Metastatic Pheochromocytomas and Paragangliomas (MPPGL)
Camilo Jimenez, MD
UT MD Anderson Cancer Center
This session will cover the challenging topic of the management of metatstatic Pheochromocytomas and Paragangliomas (MPPGLs). Clinical predictors of metastases, current evidence-based pharmacotherapeutic agents used to treat individuals living with MPPGLs, and emerging therapies for patients with MPPGLs will be discussed.
Camilo Jimenez, MD
UT MD Anderson Cancer Center